News

FFAR Funds Veterinary Research to Address Pandemic Diseases

In response to the coronavirus pandemic, the Foundation for Food and Agriculture Research (FFAR) is funding five additional Vet Fellowships to conduct pandemic and zoonotic research. The FFAR Vet Fellows program equips veterinary students with the expertise to address future agricultural challenges.

Up to 75 percent of emerging infectious diseases are zoonotic, meaning a pathogen can spread from animals to humans. Both coronaviruses and influenza viruses can be zoonotic and can be found in agricultural animals such as poultry and pigs. Research on food-animal production and veterinary medicine can reduce the threat of zoonotic pathogens. Yet, veterinary students have limited opportunities to research zoonotic diseases in agriculture.

“The coronavirus is an example of how pathogens can move between humans and animals,” said FFAR’s Executive Director Sally Rockey. “Understanding new diseases in animals, and especially how they spread, is vital to slowing transmission and developing remedies. FFAR is expanding the Vet Fellows to assure we have the expertise in the veterinary community to address what could be future pandemics.”

A recent JAVMA article agrees that veterinarians are needed in the research field to be part of the solution. FFAR is ensuring that the future scientific workforce includes veterinarians with expertise in zoonotic pathogens by funding five additional Vet Fellowships to conduct research on pathogens that threaten agricultural productivity and human health. To bolster the scientific workforce in response to the coronavirus, FFAR is not requiring the 2020 Vet Fellows to secure matching funds. Additionally, FFAR and the Association of American Veterinary Medical Colleges (AAVMC), who partners with FFAR to administer the program, extended the nomination deadline to May 6, 2020.

The FFAR Vet Fellows program will still support ten students to conduct research on agricultural productivity, public health and environmental sustainability. Information about applying for the FFAR Vet Fellows Program is available on FFAR’s website. The fifteen 2020 FFAR Vet Fellows will be announced in summer 2020.

Recent News

06/02/2026

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

TearSolutions, Inc. (“TearSolutions”), a clinical-stage biotechnology company developing novel ophthalmic therapeutics, today announced receiving Food and Drug Administration (FDA) Orphan Drug (ODD) and Fast Track Designations for Lacripep in Neurotrophic Keratitis (NK) and initiating a Phase 2 clinical trial with first patients dosed. The FDA’s ODD provides incentives, including tax credits for clinical testing and

06/02/2026

Contraline Announces $92.5 Million Series B Financing to Advance NES/T Male Contraceptive into Late-Stage Development

Contraline, Inc., a clinical-stage biopharmaceutical company developing novel male contraceptives, today announced the closing of a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management, with participation from GV (Google Ventures), Lumira Ventures, Invus, and other new and existing investors. In conjunction with the closing of the Series B financing,

06/02/2026

GEN Names BioHealth Capital Region a Top 3 U.S. Biopharma Cluster for Fourth Year in a Row

The BioHealth Capital Region, spanning Maryland, Virginia, and Washington, D.C., has once again been named one of the nation’s Top 3 biopharma clusters by Genetic Engineering & Biotechnology News (GEN), marking the region’s fourth consecutive year in the Top 3. GEN’s 2026 “Top 10 U.S. Biopharma Clusters” ranking was authored by Alex Philippidis, Senior Business